These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17264244)

  • 1. Lymphomatoid granulomatosis in a patient previously diagnosed with a gastrointestinal stromal tumour and treated with imatinib.
    Salmons N; Gregg RJ; Pallalau A; Woolhouse I; Geh I; Tanière P
    J Clin Pathol; 2007 Feb; 60(2):199-201. PubMed ID: 17264244
    [No Abstract]   [Full Text] [Related]  

  • 2. Imatinib mesylate-induced acute hepatitis in a patient treated for gastrointestinal stromal tumour.
    Pariente A; Etcharry F; Cales V; Laborde Y; Ferrari S; Biour M
    Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):785-7. PubMed ID: 16772838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous small-cell lung cancer and gastrointestinal stromal tumor: a case report.
    Girard N; Cottin V; Lapalus MG; Tronc F; Cordier JF
    Presse Med; 2009 Jan; 38(1):148-50. PubMed ID: 19028071
    [No Abstract]   [Full Text] [Related]  

  • 4. Intolerance to imatinib in gastrointestinal stromal tumors: a case report and a review of literature.
    Akasbi Y; Arifi S; Brahmi SA; El Mrabet FZ; Mellas N; Mernisi FZ; El Mesbahi O
    J Gastrointest Cancer; 2014 Dec; 45 Suppl 1():71-3. PubMed ID: 24006243
    [No Abstract]   [Full Text] [Related]  

  • 5. Imatinib-induced interstitial lung disease and sunitinib-associated intra-tumour haemorrhage.
    Loong HH; Yeo W
    Hong Kong Med J; 2008 Dec; 14(6):495-8. PubMed ID: 19060352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An acute hepatitis resembling autoimmune hepatitis occurring during imatinib therapy in a gastrointestinal stromal tumor patient.
    Aliberti S; Grignani G; Allione P; Fizzotti M; Galatola G; Pisacane A; Aglietta M
    Am J Clin Oncol; 2009 Dec; 32(6):640-1. PubMed ID: 19955903
    [No Abstract]   [Full Text] [Related]  

  • 7. [Carney triad: clinicopathologic study of 2 cases with molecular analysis].
    Xu C; Hou YY; Qi WD; Lu SH; Hou J; Tan YS; Qin J; Sun YH
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):626-7. PubMed ID: 20079194
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphomatoid granulomatosis induced by imatinib-treatment.
    Yazdi AS; Metzler G; Weyrauch S; Berneburg M; Bitzer M; Müller-Hermelink HK; Röcken M
    Arch Dermatol; 2007 Sep; 143(9):1222-3. PubMed ID: 17875901
    [No Abstract]   [Full Text] [Related]  

  • 9. Imatinib induced pyoderma gangrenosum.
    Pinato DJ; Sharma R
    J Postgrad Med; 2013; 59(3):244-5. PubMed ID: 24029213
    [No Abstract]   [Full Text] [Related]  

  • 10. Transient respiratory failure possibly associated to imatinib.
    Lengerke C; Brümmendorf T; Herrlinger U; Horger M; Kanz L; Hartmann JT
    Invest New Drugs; 2005 Mar; 23(2):137-8. PubMed ID: 15744589
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
    Choi H; Charnsangavej C; Faria SC; Macapinlac HA; Burgess MA; Patel SR; Chen LL; Podoloff DA; Benjamin RS
    J Clin Oncol; 2007 May; 25(13):1753-9. PubMed ID: 17470865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facial hyperpigmentation during imatinib therapy for gastrointestinal stromal tumor.
    Hamza I; Gaies E; Kastalli S; Daghfous R; El Aidli S
    Therapie; 2014; 69(3):245-7. PubMed ID: 24934821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acne rosacea associated imatinib mesylate in a gastrointestinal stromal tumor patient.
    Demirci U; Coskun U; Erdem O; Ozturk B; Bilge Yilmaz I; Benekli M; Buyukberber S
    J Oncol Pharm Pract; 2011 Sep; 17(3):285-7. PubMed ID: 20551113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous hemoperitoneum in recurrent jejunal gastrointestinal stromal tumor after imatinib therapy.
    Yin TC; Fan WC; Huang CJ; Hsieh JS
    Kaohsiung J Med Sci; 2013 Jul; 29(7):402-3. PubMed ID: 23768706
    [No Abstract]   [Full Text] [Related]  

  • 15. Imatinib-induced bone edema: case report and review of literature.
    dos Santos LV; Lima JP; Abdalla KC; Bragagnoli AC; Santos FA; dos Anjos Jácome A; Porto FE
    J Natl Compr Canc Netw; 2013 Oct; 11(10):1187-91. PubMed ID: 24142819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal stromal tumor with metastases in an adult woman treated with imatinib mesylate: MDCT findings.
    Busalacchi PJ; de la Calle MA; Torroba A; Del Río ST
    AJR Am J Roentgenol; 2005 Mar; 184(3 Suppl):S58-61. PubMed ID: 15728023
    [No Abstract]   [Full Text] [Related]  

  • 17. Hair graying and loss induced by imatinib mesylate.
    Yun SK; Song KH; Hwang SR; Kim HU; Lee NR; Park J
    J Dermatol; 2014 Jan; 41(1):107-8. PubMed ID: 24354806
    [No Abstract]   [Full Text] [Related]  

  • 18. Esophageal gastrointestinal stromal tumor with pulmonary and bone metastases.
    Ozan E; Oztekin O; Alacacioğlu A; Aykaş A; Postaci H; Adibelli Z
    Diagn Interv Radiol; 2010 Sep; 16(3):217-20. PubMed ID: 19838991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lichenoid drug eruption with hyperpigmentation caused by imatinib mesylate.
    Kagimoto Y; Mizuashi M; Kikuchi K; Aiba S
    Int J Dermatol; 2014 Mar; 53(3):e161-2. PubMed ID: 23786260
    [No Abstract]   [Full Text] [Related]  

  • 20. Soft tissue calcification secondary to imatinib mesylate in a patient with gastrointestinal stromal tumor.
    Enck RE; Abushahin F; Bossaer JB
    J Oncol Pharm Pract; 2014 Apr; 20(2):137-40. PubMed ID: 23676509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.